Rhythm Pharmaceuticals, Inc. ( RYTM) - Key Metrics
RYTM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.86 | -$0.71 | -$0.38 | -$0.39 |
| 2025Q3 | $0.80 | -$0.82 | -$0.41 | -$0.41 |
| 2025Q2 | $0.76 | -$0.73 | -$0.37 | -$0.37 |
| 2025Q1 | $0.52 | -$0.78 | -$0.64 | -$0.64 |
RYTM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | -0.02% | -37.67 |
| 2025Q3 | -2.60% | -30.71 |
| 2025Q2 | -5.73% | -21.57 |
| 2025Q1 | ? | -16.87 |
RYTM Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -0.75% | ? |
| 2025Q4 | -0.37% | 0.00% |
| 2025Q3 | -0.41% | 0.02% |
| 2025Q2 | -0.58% | 0.07% |
| 2025Q1 | -1.21% | ? |
RYTM
Price: $90.63
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.13 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 483700
Ebitda: -8.2 millionMarket Capitalization: 5.9 billion